An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
NCT03740230
·
clinicaltrials.gov ↗
COMPLETED
Status
3134
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C
Sponsor
AbbVie